$0.3779
-0.011[-2.83%]
At close: Apr 17
$0.3779
0[0.00%]
PreMarket: 7:51PM EDT
Singular Genomics Sys
(NASDAQ:OMIC)Singular Genomics Sys Stock (NASDAQ:OMIC), Analyst Ratings, Price Targets, Predictions
Singular Genomics Systems Inc has a consensus price target of $6.87, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from UBS, Goldman Sachs, and Goldman Sachs on March 20, 2024, January 23, 2024, and January 22, 2024. With an average price target of $0.73 between UBS, Goldman Sachs, and Goldman Sachs, there's an implied 94.05% upside for Singular Genomics Systems Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
UBS
Goldman Sachs
B of A Securities
Cowen & Co.
JP Morgan
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Singular Genomics Sys
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/20/2024 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 32.31% | UBS | John Sourbeer | $0.4 → $0.5 | Maintains | Neutral | Get Alert |
| 01/23/2024 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 124.93% | Goldman Sachs | Matthew Sykes | $0.95 → $0.85 | Maintains | Neutral | Get Alert |
| 01/22/2024 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 124.93% | Goldman Sachs | Matthew Sykes | $0.95 → $0.85 | Maintains | Neutral | Get Alert |
| 08/10/2023 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 164.62% | Goldman Sachs | Matthew Sykes | $1.15 → $1 | Maintains | Neutral | Get Alert |
| 11/08/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 693.86% | Goldman Sachs | Matthew Sykes | $3.5 → $3 | Maintains | Neutral | Get Alert |
| 08/17/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 1090.79% | UBS | John Sourbeer | $10 → $4.5 | Downgrade | Buy → Neutral | Get Alert |
| 08/10/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 693.86% | B of A Securities | Michael Ryskin | → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/10/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 826.17% | Goldman Sachs | Matthew Sykes | → $3.5 | Downgrade | Buy → Neutral | Get Alert |
| 07/14/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 1223.1% | Goldman Sachs | Matthew Sykes | $9.5 → $5 | Maintains | Buy | Get Alert |
| 05/11/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 2413.89% | Goldman Sachs | Matthew Sykes | $11 → $9.5 | Maintains | Buy | Get Alert |
| 04/13/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 2810.82% | Goldman Sachs | Matthew Sykes | $17 → $11 | Maintains | Buy | Get Alert |
| 01/07/2022 | OMIC | Buy Now | Singular Genomics Sys | $0.38 | 5457.03% | B of A Securities | Michael Ryskin | → $21 | Upgrade | Neutral → Buy | Get Alert |
| 06/21/2021 | OMIC | Buy Now | Singular Genomics Systems | $0.38 | 6780.13% | B of A Securities | Michael Ryskin | — | Initiates | → Neutral | Get Alert |
| 06/21/2021 | OMIC | Buy Now | Singular Genomics Systems | $0.38 | — | Cowen & Co. | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
| 06/21/2021 | OMIC | Buy Now | Singular Genomics Systems | $0.38 | 7838.61% | JP Morgan | Tycho Peterson | — | Initiates | → Overweight | Get Alert |
| 06/21/2021 | OMIC | Buy Now | Singular Genomics Systems | $0.38 | 9161.71% | Goldman Sachs | Matthew Sykes | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Singular Genomics Sys (OMIC)?
The latest price target for Singular Genomics Sys (NASDAQ: OMIC) was reported by UBS on March 20, 2024. The analyst firm set a price target for $0.50 expecting OMIC to rise to within 12 months (a possible 32.31% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Singular Genomics Sys (OMIC)?
The latest analyst rating for Singular Genomics Sys (NASDAQ: OMIC) was provided by UBS, and Singular Genomics Sys maintained their neutral rating.
When was the last upgrade for Singular Genomics Sys (OMIC)?
The last upgrade for Singular Genomics Systems Inc happened on January 7, 2022 when B of A Securities raised their price target to $21. B of A Securities previously had a neutral for Singular Genomics Systems Inc.
When was the last downgrade for Singular Genomics Sys (OMIC)?
The last downgrade for Singular Genomics Systems Inc happened on August 17, 2022 when UBS changed their price target from $10 to $4.5 for Singular Genomics Systems Inc.
When is the next analyst rating going to be posted or updated for Singular Genomics Sys (OMIC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Singular Genomics Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Singular Genomics Sys was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.
Is the Analyst Rating Singular Genomics Sys (OMIC) correct?
While ratings are subjective and will change, the latest Singular Genomics Sys (OMIC) rating was a maintained with a price target of $0.40 to $0.50. The current price Singular Genomics Sys (OMIC) is trading at is $0.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.